Product Name :
Mivacurium chloride
Description:
Mivacurium chloride is a rapid, non-depolarising, neuromuscular blocking agent of short duration, used therefore as anesthetic, to provide skeletal muscle relaxation in minor surgical operations, in emergency surgical procedures of short to intermediate duration and during intubation of the trachea.
CAS:
106861-44-3
Molecular Weight:
1100.17
Formula:
C58H80Cl2N2O14
Chemical Name:
2-(3-{[8-(3-{6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propoxy)-8-oxooct-4-enoyl]oxy}propyl)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-ium dichloride
Smiles :
[Cl-].[Cl-].C[N+]1(CCC2=CC(OC)=C(C=C2C1CC1=CC(OC)=C(OC)C(=C1)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCC2=CC(OC)=C(C=C2C1CC1=CC(OC)=C(OC)C(=C1)OC)OC
InChiKey:
WMSYWJSZGVOIJW-QDBORUFSSA-L
InChi :
InChI=1S/C58H80N2O14.2ClH/c1-59(25-21-41-35-47(63-3)49(65-5)37-43(41)45(59)29-39-31-51(67-7)57(71-11)52(32-39)68-8)23-17-27-73-55(61)19-15-13-14-16-20-56(62)74-28-18-24-60(2)26-22-42-36-48(64-4)50(66-6)38-44(42)46(60)30-40-33-53(69-9)58(72-12)54(34-40)70-10;;/h13-14,31-38,45-46H,15-30H2,1-12H3;2*1H/q+2;;/p-2/b14-13+;;
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Mivacurium chloride is a rapid, non-depolarising, neuromuscular blocking agent of short duration, used therefore as anesthetic, to provide skeletal muscle relaxation in minor surgical operations, in emergency surgical procedures of short to intermediate duration and during intubation of the trachea.|Product information|CAS Number: 106861-44-3|Molecular Weight: 1100.17|Formula: C58H80Cl2N2O14|Chemical Name: 2-(3-{[8-(3-{6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propoxy)-8-oxooct-4-enoyl]oxy}propyl)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-ium dichloride|Smiles: [Cl-].[Cl-].C[N+]1(CCC2=CC(OC)=C(C=C2C1CC1=CC(OC)=C(OC)C(=C1)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCC2=CC(OC)=C(C=C2C1CC1=CC(OC)=C(OC)C(=C1)OC)OC|InChiKey: WMSYWJSZGVOIJW-QDBORUFSSA-L|InChi: InChI=1S/C58H80N2O14.{{Mepolizumab (anti-IL5)} web|{Mepolizumab (anti-IL5)} Interleukin Related|{Mepolizumab (anti-IL5)} Protocol|{Mepolizumab (anti-IL5)} Description|{Mepolizumab (anti-IL5)} custom synthesis|{Mepolizumab (anti-IL5)} Epigenetic Reader Domain} 2ClH/c1-59(25-21-41-35-47(63-3)49(65-5)37-43(41)45(59)29-39-31-51(67-7)57(71-11)52(32-39)68-8)23-17-27-73-55(61)19-15-13-14-16-20-56(62)74-28-18-24-60(2)26-22-42-36-48(64-4)50(66-6)38-44(42)46(60)30-40-33-53(69-9)58(72-12)54(34-40)70-10;;/h13-14,31-38,45-46H,15-30H2,1-12H3;2*1H/q+2;;/p-2/b14-13+;;|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: Solubility (25°C).{{Tozorakimab} web|{Tozorakimab} Immunology/Inflammation|{Tozorakimab} Purity & Documentation|{Tozorakimab} In Vivo|{Tozorakimab} custom synthesis|{Tozorakimab} Cancer} 100 mg/mL(90.PMID:25040798 89 mM). 100 mg/mL(90.89 mM).|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|References:|Delu Che, et al. Mivacurium Induce Mast Cell Activation and Pseudo-Allergic Reactions via MAS-related G Protein Coupled receptor-X2. Cell Immunol. 2018 Oct;332:121-128.Matthias Paul, et al. The Potency of New Muscle Relaxants on Recombinant Muscle-Type Acetylcholine Receptors. Anesth Analg. 2002 Mar;94(3):597-603; table of contents.J E Caldwell. New Skeletal Muscle Relaxants. Int Anesthesiol Clin. Winter 1995;33(1):39-60. Products are for research use only. Not for human use.|
